PENNY WATCH

[Stock Rockstar]

CDXI Board of Directors has Some Major Biotech Players

(NEW YORK)--Cardax, Inc. (OTCQB: CDXI), a a development stage life sciences company, announced an online interview to discuss current company operations, and potential benefits of astaxanthin as an anti-inflammatory product.

BASF Partnership (major company)

CDXI and BASF, the world's largest chemical company, have entered into an agreement related to the development of a proprietary and scalable process to cost-effectively manufacture a competitively differentiated, pharmaceutical-grade, "nature-identical" astaxanthin with a defined molecular structure ("ASTX-1").

Look at the Board

Frank Herringer, the former Chairman of Transamerica, and currently member of the board at Amgen, Inc. In addition, George W. Bickerstaff, the former CFO of Novartis Pharma AG, and Tamar D. Howson, former SVP, Corporate and Business Development at Bristol-Myers Squibb to name a few.

Read this Interview and you will realize CDXI isnt your run of the mill penny stock
http://www.wallstreetnewscast.com/profile/cdxi.html